189 related articles for article (PubMed ID: 28184930)
1. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1.
Tan Y; Wei X; Zhang W; Wang X; Wang K; Du B; Xiao J
Oncol Rep; 2017 Mar; 37(3):1833-1841. PubMed ID: 28184930
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
Zhang M; Zhou X; Zhou K
Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
[TBL] [Abstract][Full Text] [Related]
4. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
5. [Radiosensitivity of nasopharyngeal carcinoma in relation to cell cycle synchronization effect of tumor necrosis factor alpha].
Yuan J; Sun N; Wang LJ; Tian W; Zhou XM; Chen DB; Gu HB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):374-6. PubMed ID: 17425997
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
He J; Cai L; Chen Y; He Y; Wang M; Tang J; Guan H; Wang J; Peng X
Radiother Oncol; 2018 Oct; 129(1):30-37. PubMed ID: 29519627
[TBL] [Abstract][Full Text] [Related]
7. Famitinib enhances nasopharyngeal cancer cell radiosensitivity by attenuating radiation-induced phosphorylation of platelet-derived growth factor receptor and c-kit and inhibiting microvessel formation.
Mu X; Ma J; Zhang Z; Zhou H; Xu S; Qin Y; Huang J; Yang K; Wu G
Int J Radiat Biol; 2015; 91(9):771-6. PubMed ID: 26073526
[TBL] [Abstract][Full Text] [Related]
8. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
[TBL] [Abstract][Full Text] [Related]
9. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
10. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression.
Zhang C; Yang X; Zhang Q; Yang B; Xu L; Qin Q; Zhu H; Liu J; Cai J; Tao G; Ma J; Ge X; Zhang S; Cheng H; Sun X
Acta Otolaryngol; 2014 Feb; 134(2):185-92. PubMed ID: 24325635
[TBL] [Abstract][Full Text] [Related]
11. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
[TBL] [Abstract][Full Text] [Related]
13. The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions.
Yang M; Yang Y; Cui H; Guan Z; Yang Y; Zhang H; Chen X; Zhu H; Yang X; Cai J; Cheng H; Sun X
Tumori; 2016; 102(2):135-43. PubMed ID: 26357974
[TBL] [Abstract][Full Text] [Related]
14. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma.
Wu LZ; Huang ML; Qi CL; Shen LJ; Zou Y; Yang R; Sheng JF; Chen SM
Bioengineered; 2021 Dec; 12(1):3398-3409. PubMed ID: 34224316
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
[TBL] [Abstract][Full Text] [Related]
17. Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown.
Wu LZ; Zou Y; Wang BR; Ni HF; Kong YG; Hua QQ; Chen SM
J Transl Med; 2023 Nov; 21(1):792. PubMed ID: 37940975
[TBL] [Abstract][Full Text] [Related]
18. [Combining FCU/5-FU suicide gene/prodrug system and radiation in treating nasopharyngeal carcinoma: an experimental study].
Tang YY; Zhao SP; Xu J; Zhong Y; Xiao JY
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):483-7. PubMed ID: 17069702
[TBL] [Abstract][Full Text] [Related]
19. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
20. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro].
Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
